How to Classify Custom Wet Wipes for U.S. Claims and Intended Use

For custom wet wipes proposed for U.S. sale, the first procurement decision is not substrate, pack count, fragrance, or price. It is the product’s intended use and the claims that will appear in the brief, packaging, sales materials, and supplier discussions. A wipe intended to cleanse or moisturize skin follows a different U.S. regulatory route from a wipe intended to treat a skin condition, clean an object, or control germs on an inanimate surface. [1]

For a procurement engineer, the practical rule is simple: write one controlled intended-use statement, screen every proposed claim against that statement, and freeze both before issuing an RFQ. This prevents suppliers from quoting products that appear physically similar but are being developed for materially different product concepts and regulatory pathways.

1. Start the Custom Wet-Wipe Brief With Intended Use

Intended use answers two questions: what is the wipe meant to act on? and what outcome is being claimed? The first question distinguishes skin, objects, and inanimate surfaces. The second distinguishes ordinary cleansing or moisturizing from therapeutic treatment or germ-control claims.

A procurement brief should not combine these categories casually. For example, a baby or personal cleansing wipe and a wipe claiming to kill germs on skin may both be supplied as pre-moistened disposable sheets, but the FDA describes them differently based on intended purpose. [1] Similarly, a kitchen wipe that removes dirt from an object is not the same concept as a wipe intended to control germs on an inanimate surface. [1]

Before formulation discussions or quotation requests begin, the buyer should record:

the target user or target being cleaned or treated;
the single intended-use statement;
all proposed front-of-pack, back-panel, e-commerce, and marketing claims;
whether the concept is skin cleansing or moisturizing, therapeutic skin use, object cleaning, inanimate-surface sanitizing or disinfecting, or a flushable toilet-wipe concept; and
the internal owner responsible for approving claim language.

2. U.S. Routing for Skin-Cleansing and Moisturizing Wipes

FDA states that wipes intended to cleanse or moisturize skin are regulated as cosmetics. The examples identified by FDA include wipes for baby care, hand washing, makeup removal, washing the body when bathing is not practical, feminine cleansing, and other personal cleansing. [1]

For early sourcing purposes, a custom wipe concept can remain in this screening category when its intended use is limited to cleansing or moisturizing skin and the proposed claims remain consistent with that purpose. This is a claims-control decision, not a determination that a finished product is compliant or suitable for sale.

Custom Wet Wipes: Intended Use and U.S. Pathway Screening Matrix
Proposed intended use	Example product concept	Target	Claim category to review	FDA-described U.S. route	Pre-RFQ action
Cleanse or moisturize skin	Baby-care, hand-and-mouth, personal-cleansing, or body-cleansing wipe	Skin	Cleansing or moisturizing	Cosmetic [1]	Lock a skin-cleansing or moisturizing intended-use statement and remove claims that introduce therapeutic purpose.
Therapeutic skin use	Wipe presented as killing germs on skin or treating a skin condition	Skin	Therapeutic claim	Drug [1]	Escalate for product-specific regulatory review before supplier quotation and packaging development.
Clean objects	Household or kitchen object-cleaning wipe	Objects	Object-cleaning claim	CPSC-described oversight [1]	Keep claims limited to the approved cleaning concept; do not add germ-control wording without review.
Control germs on inanimate surfaces	Surface sanitizing or disinfecting wipe	Inanimate surfaces	Sanitizing or disinfecting claim	EPA-described regulation [1]	Escalate the concept for pathway and claim review before RFQ release.

The matrix is a pre-RFQ screening tool. It does not establish detailed labeling, registration, ingredient, testing, or documentation obligations for an individual product.

3. When Therapeutic Skin Claims Change the Product Route

FDA states that wipes intended for a therapeutic purpose are drugs under the law. FDA’s examples include wipes intended to kill germs on skin or treat acne, diaper rash, or other skin conditions. [1]

This distinction means that procurement teams should screen words, not only product names. A project initially described as a “baby wipe,” “personal wipe,” or “hand wipe” should be re-routed for review if its proposed claim set introduces a therapeutic purpose. The same control should apply to supplier-proposed copy, retailer copy, visual claims, and translated marketing text.

Claims-control questions for therapeutic concepts

Does the proposed wording state or imply that the wipe kills germs on skin?
Does it state or imply treatment of acne, diaper rash, or another skin condition?
Has any therapeutic language been added after the initial product brief was approved?
Is the supplier quoting the same intended-use category that appears in the buyer’s internal brief?

If the answer to any of these questions is yes, the buyer should classify the concept as requiring product-specific regulatory review rather than continue under a cleansing or moisturizing brief. This avoids a mismatch between the commercial concept being quoted and the claims being developed.

4. Separate Object Cleaning From Inanimate-Surface Sanitizing or Disinfecting

For household and kitchen concepts, the target of the claim matters. FDA states that wipes intended for cleansing objects in homes, workplaces, gyms, and public places are regulated by the Consumer Product Safety Commission. FDA also states that wipes intended to control germs on inanimate surfaces are regulated by the Environmental Protection Agency. [1]

Accordingly, “cleans objects” and “controls germs on inanimate surfaces” should be treated as separate routes in a U.S.-bound sourcing brief. The latter language should not be introduced as a marketing enhancement after the supplier has quoted an object-cleaning wipe. It changes the product concept that must be reviewed.

Buyers should also avoid treating a product name such as “kitchen wipe” as a classification. The product name is not sufficient because the relevant distinction is the intended use and claim language: cleaning an object versus controlling germs on an inanimate surface. [1]

5. Handle Flushable Wipe Concepts as an Evidence Review Item

FDA notes that some disposable wipes are labeled as flushable. [1] The available source does not identify a product-specific flushability test method, test result, or validation outcome for a particular supplier or wipe. Therefore, a flushable label alone should not be treated in procurement as product-specific technical validation.

For a custom flushable toilet-wipe concept, the appropriate early-stage action is to create an evidence intake gate. The purpose is not to declare a product flushable; it is to make sure the buyer can identify what product was tested, what claim is proposed, and what documentation is available for internal or external review.

Flushable Claim Documentation Intake Checklist
Documentation field	Buyer screening question	RFQ handling
Exact product identifier	Can the document be tied to the proposed wipe and pack configuration?	Request a product identifier and revision reference.
Proposed flushable claim	What exact wording is intended for packaging and marketing?	Attach the proposed claim to the RFQ approval record.
Named test method	Does the supplier identify the method used?	Request the method name and version where available.
Complete test report	Is a complete report available rather than an unsupported statement?	Request the report for review; do not infer results that are not shown.
Tested product configuration	Does the record identify the substrate, lotion, dimensions, and pack-related configuration tested?	Record any differences between the tested and quoted configurations.
Target-market claims review status	Has the final U.S. claim been reviewed by the responsible owner?	Hold claim release until the review status is documented.

This checklist does not specify a required U.S. test method, pass/fail threshold, or regulatory conclusion. Those items are outside the available source and require product-specific review.

6. Convert Classification Into a Sourcing Brief and RFQ Gate

The most useful control is to make intended use and approved claim language part of the RFQ baseline. Suppliers can then quote against one defined product concept rather than interpreting a broad term such as “antibacterial,” “kitchen,” “baby,” or “flushable” differently.

Pre-RFQ Claims-Control Workflow for U.S.-Bound Custom Wet Wipes

Define intended use: State whether the wipe is for skin cleansing or moisturizing, therapeutic skin use, object cleaning, inanimate-surface germ control, or a flushable toilet-wipe concept.
Identify the target: Record skin, object, or inanimate surface, as applicable.
Screen all claim language: Review packaging, product-page, sales, and supplier-proposed claims against the intended use.
Assign the route for review: Use the FDA-described cosmetic, drug, CPSC, or EPA pathway distinction as the screening basis. [1]
Request supporting documents: For a flushable claim, obtain identifiable documentation for review rather than relying on the label alone.
Freeze RFQ scope: Release the RFQ only after the intended use, claim set, target market, and review owner are recorded.

Minimum RFQ claims-control fields

Product intended-use statement.
Target user or cleaned surface.
Proposed front-of-pack, marketing, and e-commerce claims.
Selected concept category: skin cleansing/moisturizing, therapeutic skin use, object cleaning, inanimate-surface sanitizing/disinfecting, or flushable.
U.S. target market and sales channel.
For flushable concepts, identifiable supporting documentation requested for review.
Internal compliance-review owner, decision date, and approval status.

These fields are procurement controls. They do not substitute for product-specific regulatory assessment, technical testing, or legal advice.

Conclusion

Custom wet wipes should be classified for U.S. sourcing by intended use and claims before development and quotation begin. FDA describes skin-cleansing and moisturizing wipes as cosmetics; wipes with therapeutic skin purposes such as killing germs on skin or treating acne or diaper rash as drugs; object-cleaning wipes as associated with CPSC oversight; and wipes intended to control germs on inanimate surfaces as EPA-regulated. [1]

For buyers, the decision tool is a controlled product brief: define the target, approve the claims, route the concept for the appropriate review, and keep the approved wording fixed in the RFQ. For flushable concepts, request identifiable supporting documents and do not equate a flushable label with product-specific validation. Buyers can use the specification and qualification fields in this guide to structure a technical RFQ and compare supplier responses on a consistent basis.

Scope and limitations

This guide is an early product-brief and sourcing-screening tool for custom wet wipes proposed for U.S. sale. It is limited to the U.S. classifications described in the cited FDA guidance and should be checked against the current regulatory status before publication or product launch. It does not provide product-specific legal conclusions, labeling text, ingredient requirements, registration procedures, test thresholds, formulation specifications, or a determination that any individual wipe is flushable, biodegradable, safe, compliant, or suitable for a particular use.

References

[1] U.S. Food and Drug Administration. Disposable Wipes. Updated October 28, 2024. https://www.fda.gov/cosmetics/cosmetic-products/disposable-wipes. Accessed August 5, 2026.